Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 October 2024 | Story Litha Banjatwa | Photo Supplied
Matriculant of the year 2024
This year’s winner, Jayden Leech (centre), deputy head boy and hockey captain at Grey College.

For more than four decades, the University of the Free State (UFS) has used its annual Matriculant of the Year competition to attract the country’s top matriculants. This prestigious award recognises and celebrates the exceptional achievements of South African high school students who excel in academics, sports, culture, and leadership.

This year’s winner, Jayden Leech, deputy head boy and hockey captain at Grey College, stands out not only for his academic average of 90% but also for his sporting achievements. He has represented South Africa in karate and has been a member of the Free State Hockey and Waterpolo teams for the past three years. Jayden has been selected to pursue a medical degree.

The competition is closely aligned with the UFS’s Vision 130, which envisions a future where academic excellence, innovation, and societal impact are prioritised. “By recognising academic success, creativity, resilience, and leadership potential, the university aims to attract the brightest minds to join its community. This competition serves as a platform to identify and nurture future leaders who will help address South Africa's pressing challenges,” says Nomonde Mbadi, Director of Student Recruitment Services.

This year, the competition attracted 60 applicants, with a strong representation of women - 43 women and 17 men. The Free State province led with 28 entries, followed by North West, KwaZulu-Natal, and Gauteng. Popular fields of study among applicants included Medicine (MBChB), Accounting, Engineering, and Law. While the overall academic average of all entries was an impressive 81%, the top 14 finalists achieved an outstanding average of 85%.

Through a series of interviews and group activities, candidates were assessed on their critical thinking, communication skills, and ability to collaborate effectively. The Matriculant of the Year is ultimately selected for their overall balance, leadership potential, and capacity to serve as an ambassador for the UFS.

The Matriculant of the Year competition reflects the UFS’s commitment to fostering a diverse, inclusive, and equitable learning environment, aligned with the university’s values of social justice and sustainability. “By aligning this competition with Vision 130, we reaffirm the UFS’s dedication to transforming lives, creating opportunities, and shaping the next generation of leaders who will drive societal and economic progress,’’ adds Mbadi. 

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept